Cosmo Feilding-Mellen - Nov 5, 2025 Form 4 Insider Report for Atai Beckley N.V. (ATAI)

Role
Director
Signature
/s/ Ryan Barrett, as attorney in fact
Stock symbol
ATAI
Transactions as of
Nov 5, 2025
Transactions value $
$0
Form type
4
Date filed
11/6/2025, 08:49 PM
Next filing
Nov 26, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Feilding-Mellen Cosmo Director C/O ATAI BECKLEY N.V., PROF. J.H. BAVINCKLAAN 7, AMSTERDAM, NETHERLANDS /s/ Ryan Barrett, as attorney in fact 2025-11-06 0002094202

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATAI Common Shares Award +7.7M 7.7M Nov 5, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATAI Stock Option Award $0 +103K $0.00 103K Nov 5, 2025 Common Shares 103K $4.48 Direct F2
transaction ATAI Stock Option Award $0 +40.4K $0.00 40.4K Nov 5, 2025 Common Shares 40.4K $4.48 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On November 5, 2025, the Issuer completed its previously announced acquisition of the entire issued share capital of Beckley Psytech Limited ("Beckley Psytech") not already owned by the Issuer (the "Acquisition") from the shareholders of Beckley Psytech, pursuant to that certain Share Purchase Agreement, dated as of June 2, 2025, by and among the parties thereto, as amended (the "Purchase Agreement"). In connection with the Acquisition, the Company acquired all of the issued and outstanding equity interests of Beckley Psytech in exchange for an aggregate of 103,000,066 common shares of the Issuer, issued directly as share consideration or as underlying replacement awards pursuant to the Purchase Agreement.
F2 The stock option shall vest in full on the first anniversary of the grant date.
F3 The stock option shall vest in 12 substantially equal monthly installments, beginning on December 5, 2025.